作者投稿
专家审稿
编辑办公
邮件订阅
RSS
-
利益冲突 无
-
[1] 游珊珊, 姜玉新, 朱庆莉, 等.基于临床及超声声像图特征的乳腺癌风险预测模型[J].协和医学杂志, 2014, 5:26-30. http://www.cnki.com.cn/Article/CJFDTOTAL-XHYX201401011.htm [2] Rena O, Papalia E, Ruffini E, et al. The role of surgery in the management of solitary pulmonary nodule in breast cancer patients[J]. Eur J Surg Oncol, 2007, 33:546-550. http://europepmc.org/abstract/med/17267164 [3] Schonfeld SJ, Curtis RE, Anderson WF, et al. The risk of a second primary lung cancer after a first invasive breast cancer according to estrogen receptor status[J]. Cancer Causes Control, 2012, 23:1721-1728. [4] Shoji F, Yamashita N, Inoue Y, et al. Surgical resection and outcome of synchronous and metachronous primary lung cancer in breast cancer patients[J]. Anticancer Res, 2017, 37:5871-5876. http://www.ncbi.nlm.nih.gov/pubmed/28982914 [5] Wang R, Yin Z, Liu L, et al. Second primary lung cancer after breast cancer:A population-based study of 6, 269 women[J]. Front Oncol, 2018, 8:427. [6] Yang M, Nonaka D. A study of immunohistochemical differential expression in pulmonary and mammary carcinomas[J]. Mod Pathol, 2010, 23:654-661. http://jcp.bmj.com/external-ref?access_num=10.1038/modpathol.2010.38&link_type=DOI [7] Laurent E, Begueret H, Bonhomme B, et al. Sox10, gata3, gcdfp15, androgen receptor, and mammaglobin for the differential diagnosis between triple-negative breast cancer and ttf1-negative lung adenocarcinoma[J]. Am J Surg Pathol, 2019, 43:293-302. http://journals.lww.com/ajsp/Abstract/publishahead/SOX10,_GATA3,_GCDFP15,_Androgen_Receptor,_and.97715.aspx [8] Chang EY, Johnson W, Karamlou K, et al. The evaluation and treatment implications of isolated pulmonary nodules in patients with a recent history of breast cancer[J]. Am J Surg, 2006, 191:641-645. [9] Tanaka K, Shimizu K, Ohtaki Y, et al. Diagnosis and surgical resection of solitary pulmonary nodules in patients with breast cancer[J]. Mol Clin Oncol, 2013, 1:117-123. http://www.ncbi.nlm.nih.gov/pubmed/24649133 [10] Song Z, Ye T, Ma L, et al. Surgical outcomes of isolated malignant pulmonary nodules in patients with a history of breast cancer[J]. Ann Surg Oncol, 2017, 24:3748-3753. doi: 10.1245/s10434-017-6067-0 [11] Ruiterkamp J, Voogd AC, Bosscha K, et al. Impact of breast surgery on survival in patients with distant metastases at initial presentation:A systematic review of the literature[J]. Breast Cancer Res Treat, 2010, 120:9-16. doi: 10.1007/s10549-009-0670-0 [12] Badwe R, Hawaldar R, Nair N, et al. Locoregional treat-ment versus no treatment of the primary tumour in metastatic breast cancer:An open-label randomised controlled trial[J]. Lancet Oncol, 2015, 16:1380-1388. http://www.ncbi.nlm.nih.gov/pubmed/26363985 [13] Soran A, Ozmen V, Ozbas S, et al. Randomized trial comparing resection of primary tumor with no surgery in stage iv breast cancer at presentation:Protocol MF 07-01[J]. Ann Surg Oncol, 2018, 25:3141-3149. doi: 10.1245/s10434-018-6494-6 [14] King TA, Lyman JP, Gonen M, et al. Prognostic impact of 21-gene recurrence score in patients with stage iv breast cancer:Tbcrc 013[J]. J Clin Oncol, 2016, 34:2359-2365. https://mayoclinic.pure.elsevier.com/en/publications/prognostic-impact-of-21-gene-recurrence-score-in-patients-with-st [15] Fitzal F, Bjelic-Radisic V, Knauer M, et al. Impact of breast surgery in primary metastasized breast cancer:Outcomes of the prospective randomized phase iii abcsg-28 posytive trial[J]. Ann Surg, 2019, 269:1163-1169. http://europepmc.org/abstract/MED/29697452 [16] 中国抗癌协会乳腺癌专业委员会.中国抗癌协会乳腺癌诊治指南与规范(2017年版)[J].中国癌症杂志, 2017, 27:695-759. http://www.cnki.com.cn/Article/CJFDTotal-ZGAZ201709004.htm [17] 沈松杰, 孙强.中国女性乳腺癌筛查现状及适宜模式探索[J].协和医学杂志, 2018, 9:298-302. http://d.old.wanfangdata.com.cn/Periodical_xhyx201804003.aspx -
下载:
点击查看大图
图(4)
计量
- 文章访问数: 278
- HTML全文浏览量: 84
- PDF下载量: 276
- 被引次数: 0
